LZLia Meuthia Zaini

Lia Meuthia Zaini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lia Meuthia Zaini has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    PREDICTORS OF POOR VISUAL OUTCOMES IN PATIENTS WITH ENDOPHTHALMITIS AT THE PROVINCIAL REFERRAL HOSPITAL IN BANDA ACEH

    by Lia Meuthia Zaini, Enny Nilawati, Cut Putri Samira, Putri Nabillah Mulya, Dian Islami

    Introduction: Endophthalmitis is a severe intraocular infection that can lead to irreversible visual loss. Visual outcomes are influenced by several clinical and management factors, but data from Indonesia remain limited. This study aimed to describe the clinical and demographic characteristics of patients with infectious endophthalmitis and identify predictors of poor visual outcomes at a tertiary hospital in Aceh, Indonesia. Methods: This retrospective study included 94 patients diagnosed with infectious endophthalmitis at Dr. Zainoel Abidin General Hospital, Banda Aceh, between December 2021 and November 2024. Data on demographics, clinical presentation, microbiology, management, and visual acuity were extracted from medical records. Visual outcomes were categorized as <1/60 versus ?1/60. Multivariate logistic regression was performed to determine predictors of poor or unassessed outcomes. Result: The mean patient age was 52.8 years, with 63.8% male. Exogenous endophthalmitis was the predominant type (93.6%), most commonly occurring after cataract surgery (47.9%). At presentation, 88.3% of patients had VA <1/60. Vitreous cultures were positive in 28.8% of cases, with Pseudomonas spp. and Staphylococcus spp. being the most frequent isolates. The majority of patients (58.5%) underwent pars plana vitrectomy (PPV), while 12.8% required evisceration. At follow-up, 50% had VA 6/45, and 13.8% were lost to follow-up. Multivariate analysis identified poor initial VA (<1/60) (Odd Ratio (OR) 6.41, 95% CI: 1.03–39.76, p=0.046) and short follow-up (<1 month) (OR 5.13, 95% CI: 1.33–19.78, p=0.017) as independent predictors of poor or unassessed outcomes. Non-PPV management showed a non-significant trend toward worse outcomes (OR 3.29, p=0.057). Conclusion: Poor presenting visual acuity and inadequate follow-up were strong predictors of poor outcomes in endophthalmitis. These findings highlight the importance of early recognition, patient education, and system-level support for follow-up, particularly in resource-limited settings.

  • Open Access

    ENDOPHTHALMITIS IN ACEH: ANALYSIS OF MICROBIAL SPECTRUM AND ANTIBIOTIC RESISTANCE

    by Cut Putri Samira, Enny Nilawati, Lia Meuthia Zaini, Dian Islami, Putri Nabillah Mulya

    Introduction: Endophthalmitis is a rare but vision-threatening intraocular infection that requires prompt and appropriate antimicrobial therapy. The microbial spectrum and antibiotic resistance patterns vary by region, yet data from Aceh, Indonesia, are limited. This study aimed to analyze the microbial profile and antibiotic susceptibility patterns of endophthalmitis cases treated at a tertiary healthcare center in Aceh. Methods: A retrospective descriptive study was conducted using medical records of patients diagnosed with endophthalmitis at dr. Zainoel Abidin General Hospital, Banda Aceh, from January 2021 to December 2024. Data collected included demographics, predisposing factors, etiological classification, microbiological culture results, and antibiotic susceptibility profiles. Microbiological identification and susceptibility testing were performed using standard culture methods and the VITEK2 Compact system. Result: A total of 111 eyes with unilateral endophthalmitis were included. Exogenous endophthalmitis predominated (95.5%), with post–cataract surgery (36.0%), traumatic (29.7%), and keratitis-related (27.1%) cases being most common. The mean patient age was 52.7 ± 18.5 years, with male predominance (63%). Bacterial isolates were identified in 26 eyes (23.5%), with Gram-negative organisms accounting for 65.4%. Pseudomonas aeruginosa was the most frequently isolated pathogen (58.8%). Gentamicin showed the highest overall susceptibility (75.0%), while vancomycin demonstrated complete sensitivity against Gram-positive isolates. Conclusion: Endophthalmitis in Aceh is predominantly exogenous and commonly caused by Gram-negative bacteria, particularly Pseudomonas aeruginosa. Gentamicin demonstrated the highest in vitro activity, while vancomycin and ceftazidime remain key components of empirical intravitreal therapy to ensure broad antimicrobial coverage. These findings provide important local microbiological data to support evidence-based management of endophthalmitis.

  • Open Access

    Trends in CTGF Expression in Renal and Chorioretinal Tissues Following Metformin and SGLT2 Inhibitor Treatment in Diabetic Rats

    by Maimun Syukri, Lia Meuthia Zaini, Arief Sjamsulaksan Kartasasmita, Tjahjono Darminto Gondhowiardjo, Ronny Lesmana, Putri Nabillah Mulya

    BACKGROUND: Connective tissue growth factor (CTGF) plays a central role in fibrotic processes affecting both renal and retinal tissues in diabetes. Although sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to exert renoprotective and antifibrotic effects, their impact on CTGF expression in renal and retinal tissues has not been clearly established. This preliminary study was conducted to evaluate whether SGLT2 inhibitors (SGLT2i) could influence CTGF expression in the kidneys and eyes of diabetes-induced rats.METHODS: After two weeks of adaptation, 24 rats were randomized and distributed equally into four groups (n=6 each): 1) Healthy Control, healthy rats without diabetic induction; 2) Negative Control, diabetic rats induced with streptozotocin (STZ) without treatment; 3) Metformin Group, diabetic rats treated with metformin; and 4) SGLT2i Group, diabetic rats treated with empagliflozin. Following eight weeks of intervention, CTGF expression was analyzed by Western blot in renal tissue (right kidney) and chorioretinal tissue (right eye). Four samples per group yielded analyzable bands and were included in the final quantification.RESULTS: In renal tissue, CTGF levels (mean±SD) were highest in Negative Control Group (0.81±0.06). Both the Metformin Group (0.58±0.14) and SGLT2i Group (0.57±0.33) demonstrated a trend toward reduced CTGF expression. In chorioretinal tissue, CTGF values were relatively similar across groups (Healthy Control: 0.67±0.05; Negative Control: 0.63±0.12), with Metformin Group (0.61±0.12) and SGLT2i Group (0.64±0.22) showing a modest reduction trend.CONCLUSION: In diabetic rats, CTGF expression levels are markedly increased. Following treatment with metformin and SGLT2i, CTGF expression demonstrates a noticeable reduction trend.KEYWORDS: SGLT2 inhibitor, metformin, connective tissue growth factor, cellular communication network factor 2, renal, retina

  • Open Access

    HYPERTENSIVE OPTIC NEUROPATHY AS A PRESENTATION OF SYSTEMIC LUPUS ERYTHEMATOSUS

    by Lia Meuthia Zaini, Putri Nabillah Mulya

    Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organ systems, including the eyes. Hypertensive optic neuropathy is a rare but serious manifestation of SLE that may precede SLE diagnosis. This case highlights the early ocular involvement in a young patient with undiagnosed SLE. Case Report: A 21-year-old female presented to our ophthalmology clinic with blurry vision in both eyes, along with elevated blood pressure at 165/126 mmHg. Ophthalmic examination revealed visual acuity of 20/200 on both eyes, bilateral optic disc swelling, macular edema, flame-shaped hemorrhages, and cotton-wool spots. These findings are consistent with hypertensive optic neuropathy. The antihypertensive drugs were initiated and planned for intravitreal bevacizumab administration. The patient was referred to internal medicine. Laboratory tests and clinical findings indicated secondary hypertension, anemia, leukopenia, and thrombocytopenia. Immuno-serological testing confirmed a diagnosis of SLE. The patient was initiated on systemic immunosuppressive therapy. Eight weeks after the first visit, she showed significant improvement, with the resolution of macular edema and optic disc swelling. The patient’s visual acuity improved to 20/50 in the right eye (RE) and 20/20 in the left eye (LE). Discussion: Hypertension in SLE is multifactorial, involving endothelial dysfunction, kidney injury, immune activation, and autoantibodies. Hypertensive retinopathy progresses through three phases: vasoconstrictive, sclerotic, and exudative, characterized by arterial narrowing, structural vascular changes, and blood-retina barrier disruption, leading to macular edema and ischemia. Diagnosis is based on fundoscopic examination and Optical Coherence Tomography (OCT), while management focuses on blood pressure control, anti-VEGF therapy, and close monitoring to prevent further complications. Conclusion: Early detection and multidisciplinary management are crucial in preventing irreversible visual loss and systemic complications. Regular ophthalmic follow-up and blood pressure monitoring are essential in SLE management.

  • Open Access

    Expression of GLUT-1 and SGLT-2 in the Chorioretina of Streptozotocin-induced Diabetic Rats After Administration of Empagliflozin

    by Lia Meuthia Zaini, Arief S Kartasasmita, Tjahjono D Gondhowiardjo, Maimun Syukri, Ronny Lesmana

    Purpose: To assess the effect of empagliflozin on the expression of SGLT-2 and GLUT-1 in the chorioretina of streptozotocin-induced diabetic rats. Methods: An in vivo experimental study was performed on Wistar rats. After a 2-week adaptation period, the rats were allocated to one of four groups. The group allocations were as follows: (K1) negative control (no intervention); (K2) positive control injected with streptozotocin (STZ) without treatment; (K3) positive control injected with STZ and treated with metformin; and (K4) positive control injected with STZ and treated with empagliflozin. SGLT-2 and GLUT-1 expressions were examined using the Western blot technique.Results: SGLT-2 was expressed in the chorioretinal tissue of all groups; administration of SGLT-2 inhibitors could suppress its expression. The average band thickness indicated that SGLT-2 expression was higher in diabetic rats compared to rats with normal sugar levels. GLUT-1 expression was noticed in all groups based on the chorioretinal examination. It did not change in the metformin group, whereas the empagliflozin group showed a significant decrease in the GLUT-1 expression. Conclusion: Both metformin and empagliflozin suppress the expression of SGLT-2 and GLUT-1 in the chorioretina of diabetic rats. In comparison, empagliflozin seems to be more potent in reducing this expression.


  • Open Access

    Clinical characteristics and knowledge of diabetic retinopathy patients at a tertiary hospital in Aceh, Indonesia

    by Lia M. Zaini, Arief S. Kartasasmita, Tjahjono D. Gondhowiardjo, Maimun Syukri, Putri N. Mulya

    Background: Diabetic retinopathy (DR) is a significant microvascular complication of diabetes mellitus, leading to vision impairment and blindness in working-age adults globally. Aim: To evaluate the knowledge, clinical characteristics and associated factors among diabetic retinopathy patients attending an ophthalmology clinic at a tertiary hospital in Aceh from May 2020 to May 2021. Setting: The study was conducted at Zainoel Abidin General Hospital, Banda Aceh, Indonesia. Methods: A prospective cross-sectional study using consecutive sampling was conducted. Data collection involved patient history, eye examinations, laboratory tests and administering a questionnaire to assess knowledge of diabetes and diabetic retinopathy. The data were analysed using descriptive statistics and binary logistic regression. Results: Out of 173 participants, 170 were included in the study. A significant proportion had visual acuity less than 6/60 (44.1%) and proliferative diabetic retinopathy (PDR) (52.6%) with macular oedema in 11.8%. Only seven (4.1%) patients had good knowledge of diabetes and 28 (16.5%) had good knowledge of DR. A total of 113 (66.5%) patients were aware that diabetes could affect the eye and positively associated with the sex (adjusted odds ratio [AOR]: 6.18, 95% confidence interval [CI]: 1.80–21.21, P = 0.004), educational level (AOR: 4.66, 95% CI: 1.31–16.51, P = 0.017) and type of DM (AOR: 5.30, 95% CI: 1.97–14.26, P = 0.001). Conclusion: The study revealed a high incidence of vision-threatening diabetic retinopathy (VTDR), including severe non-proliferative, proliferative and significant macular oedema cases. However, patients’ knowledge of their disease was very low. Contribution: This study crucial data to the Department of Health Authority for policy decision-making.


  • Open Access

    Clinical Features and Factors Affecting the Success of Retinal Vasculitis Therapy

    by Lia Meuthia Zaini, Arief Kartasasmita

    Introduction: Retinal vasculitis is an inflammatory eye condition that threatens vision. Inflammation occurs in the branches of retinal arteries, cause by primary ocular diseases or associated with other diseases. This study aims to describe clinical features and factors affecting therapeutic success in 52 patients with retinal vasculitis. Methods: This study was conducted using retrospective cohort in Retina Clinic of Cicendo Eye Hospital for vasculitis patients from January 1st- December 31st 2017. Data were collected retrospectively from the ophthalmic records of 52 patients (74 affected eyes). Descriptive analysis was performed on all data, chi-square and eksak fisher test were used to analyze risk factor and factors affecting the success of therapy. Result: Out of 529 vasculitis and vitreous hemorrhage cases, retinal vasculitis was found in 52 patients (9.8%). Mean age of retinal vasculitis patients were 42.3 years (range: 13-74 years). 35 patients (62.3%) were men and 22 patients (42.3%) had bilateral retinal vasculitis. Most patients (73%) had positive results for history of TORCH infections, and 23.76 % for tuberculosis. At initial presentation, almost all patients (93.2%) came with chief complaint of blurry vision, 42 patients (56.8%) came with baseline visual acuity £20/200. Vitreous hemorrhage was identified from retinal examination in 43 patients (58.1%). Therapeutic success was found better in patients with systemic involvement (74,1%). Conclusion: Despite limitation of facility in our hospital, therapeutic success rate of retinal vasculitis patients was quite good. Better laboratory investigation and other supporting examinations are still needed to obtain good therapeutic results and to conduct further study about the disease. Tuberculosis, TORCH, and autoimmune test are important examination when managing retinal vasculitis.

  • Open Access

    Clinical Characteristics of Diabetic Retinopathy Patients in Eye Clinic of Zainoel Abidin General Hospital Banda Aceh, Indonesia

    by Lia Meuthia Zaini, Sri Marlinda, Annisa Meivira Budiman

    Clinical Characteristics of Diabetic Retinopathy Patients in Eye Clinic of Zainoel Abidin General Hospital Banda Aceh, Indonesia